MENU
+Compare
CNTA
Stock ticker: NASDAQ
AS OF
Apr 1 closing price
Price
$13.23
Change
-$1.15 (-8.00%)
Capitalization
1.92B

CNTA Centessa Pharmaceuticals plc Forecast, Technical & Fundamental Analysis

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company... Show more

CNTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for CNTA with price predictions
Mar 31, 2025

CNTA's Stochastic Oscillator is sitting in oversold zone for 4 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CNTA advanced for three days, in of 192 cases, the price rose further within the following month. The odds of a continued upward trend are .

CNTA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 25, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CNTA as a result. In of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for CNTA turned negative on March 21, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 32 similar instances when the indicator turned negative. In of the 32 cases the stock turned lower in the days that followed. This puts the odds of success at .

CNTA moved below its 50-day moving average on March 25, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CNTA crossed bearishly below the 50-day moving average on March 26, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CNTA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CNTA entered a downward trend on March 11, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CNTA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.388) is normal, around the industry mean (13.677). P/E Ratio (0.000) is within average values for comparable stocks, (64.969). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.870). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (243.902) is also within normal values, averaging (255.565).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CNTA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
CNTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CNTA is expected to report earnings to fall 57.44% to -35 cents per share on May 19

Centessa Pharmaceuticals plc CNTA Stock Earnings Reports
Q1'25
Est.
$-0.36
Q4'24
Missed
by $0.42
Q3'24
Beat
by $0.03
Q2'24
Missed
by $0.01
Q1'24
Beat
by $0.04
The last earnings report on March 24 showed earnings per share of -83 cents, missing the estimate of -41 cents. With 1.38M shares outstanding, the current market capitalization sits at 1.92B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1 Ashley Road
Phone
+1 617 468-5770
Employees
153
Web
https://www.centessa.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ALVSX10.58N/A
N/A
American Century Focused Lg Cap Val I
SSHFX37.68N/A
N/A
Sound Shore Investor
PEQLX35.19N/A
N/A
Putnam Large Cap Value R5
CAXIX17.57N/A
N/A
Catalyst/MAP Global Equity I
PISQX14.11N/A
N/A
Columbia Pyrford International Stk Ins 3

CNTA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CNTA has been loosely correlated with ORIC. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CNTA jumps, then ORIC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTA
1D Price
Change %
CNTA100%
-1.44%
ORIC - CNTA
37%
Loosely correlated
-9.12%
VCYT - CNTA
37%
Loosely correlated
-1.56%
XENE - CNTA
36%
Loosely correlated
-2.07%
KYMR - CNTA
36%
Loosely correlated
-7.60%
CRNX - CNTA
35%
Loosely correlated
-3.43%
More